Efficacy of Peri-operative Pirfenidone Treatment in Lung Cancer Patients With Idiopathic Pulmonary Fibrosis: A retrospective study

Trial Profile

Efficacy of Peri-operative Pirfenidone Treatment in Lung Cancer Patients With Idiopathic Pulmonary Fibrosis: A retrospective study

Completed
Phase of Trial: Phase IV

Latest Information Update: 27 Apr 2017

At a glance

  • Drugs Pirfenidone (Primary)
  • Indications Idiopathic pulmonary fibrosis; Lung cancer
  • Focus Adverse reactions
  • Most Recent Events

    • 27 Apr 2017 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top